3-(s)-(+)-(1-carbamoyl -1,1-diphenylmethyl)pyrrolidine l-(+)-tartrate
Date：2021-12-03 Categories：Related Application Product
| post date: |
dec 02,2021 |
| expiry date: |
may 31,2022 |
| detailed description: |
cas no. :134002-26-9
|
| cas registry number: |
134002-26-9
|
| synonyms: |
;(s)-diphenyl-3-pyrrolidine acetamide l-tartaric acid salt;(s)-alpha,alpha-diphenyl-3-pyrrolidineacetamide l-tartaric acid salt;darifenacin intermediate 5;(s)-α,α-diphenyl-3-pyrrolidine acetamide l-tartaric;darifenacin intermediate 8;(s)-alpha,alphal-diphenyl-3-pyrrolidineacetamide tartrate;3(s)-(+)-(1-carbamoyl-1,1-diphenylmethyl) pyrrolidine-l(+)-tartrate;3(s)-(+)-(1-carbamoyl-1,1-diphenylmethyl)pyrrolidine-l(+)-tartrate;3-(s)-(+)-(1-carbamoyl-1,1-diphenylmethyl)pyrroloidine-l-(+)-tartarate;2,2-diphenyl-2-[(3s)-pyrrolidin-3-yl]acetamide l-(+)-tartrate;2,2-diphenyl-2-[(3s)-pyrrolidin-3-yl]acetamide 2,3-dihydroxybutanedioate (1:1);(s)-alpha, alphal-diphenyl-3-pyrrolidineacetamide l-tartaric acid salt;3-(s)-(1-carbamoyl-1,1-diphenylmethyl)pyrrolidine tartrate;2,2-diphenyl-2-[(3s)-pyrrolidin-3-yl] acetamide l-(+)-tartrate;3(s)-(+)-(1-carbamoyl-1,1-diphenylmethyl) pyrrolidine-l-(+)-tartrate;(3s)-(1-carbamoyl-1,1-diphenylmethyl)pyrroloidine-l-tartarate; |
| molecular formula: |
c22h26n2o7 |
| molecular weight: |
430.45104 |
| molecular structure: |
|
